The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Growing patent filings and tier-2 innovators reflect expanding national research base
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
Subscribe To Our Newsletter & Stay Updated
